ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,630.55
-0.17%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2495
-0.01%
Brent Oil
80.87
0.08%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Veru Inc (VERU)

  7. Veru Inc (VERU) ニュース

VERU Veru Inc

1.02
0.0536 (5.55%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Veru Inc VERU NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.0536 5.55% 1.02 08:58:07
始値 安値 高値 終値 前日終値
0.99 0.98 1.0799 1.01 0.9664
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2906:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2507:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2507:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2305:10EDGAR2Form 8-K - Current report
2024/5/2221:30GLOBEVeru to Present at the Jefferies Global Healthcare..
2024/5/1808:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1808:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1521:30GLOBEVeru Announces Steven B. Heymsfield M.D. as the Principal..
2024/5/1421:30GLOBEVeru Announces Mitchell Steiner as Keynote Speaker at Biomed..
2024/5/1005:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1005:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1004:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1004:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1002:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/5/1002:02EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
2024/5/0902:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0820:00EDGAR2Form 8-K - Current report
2024/5/0819:30GLOBEVeru Reports Fiscal 2024 Second Quarter Financial Results..
2024/5/0221:30GLOBEVeru to Present at the GLP-1 Based Therapeutics Summit
2024/5/0121:30GLOBEVeru to Report Fiscal 2024 Second Quarter Financial Results..
2024/4/3021:30GLOBEVeru Enrolls First Patients in Phase 2b Clinical Trial of..
2024/4/2521:30GLOBEVeru to Present at the American Association of Clinical..
2024/4/0205:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
2024/3/2305:05GLOBEVeru Reschedules Annual Meeting of Shareholders
2024/3/1221:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
2024/2/2809:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
2024/2/2022:30GLOBEVeru Announces New Scientific Advisory Board for its..
2024/2/1606:49EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2024/2/1606:06EDGAR2Form 8-K - Current report
2024/2/1506:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0821:00EDGAR2Form 8-K - Current report
2024/2/0820:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
2024/2/0706:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0622:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
2024/1/3122:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
2024/1/2706:06EDGAR2Form 8-K - Current report
2024/1/2623:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/2623:00EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/2522:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
2024/1/0822:30GLOBEVeru Submits IND Application to FDA for the Development of..
2023/12/2706:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/1922:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
2023/12/1823:01EDGAR2Form 8-K - Current report
2023/12/1606:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1423:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
2023/12/1406:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1406:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1406:04EDGAR2Form 8-K - Current report
2023/12/1406:01GLOBEVeru Announces Proposed Public Offering of Common Stock
2023/12/0906:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..

最近閲覧した銘柄

NASDAQ
VERU
Veru
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有